EUIPO trademark

FOCUS-2

Opposition periodEUIPOFigurative markClass 5

"FOCUS-2" is a figurative mark owned by Axsome Therapeutics, filed at the EUIPO on September 1, 2026. It is in its opposition period and covers class 5 (Pharmaceuticals).

View Axsome Therapeutics portfolioGet this data via the API
Official EUIPO record
FOCUS-2 trademark as filed
As filed with the EUIPO
Status
Opposition period
Filed
September 1, 2026
Registered
Not yet
Priority date
June 1, 2026
Claimed from United States
Application no.
019416545
Registration no.
Not yet
Office
EUIPO
European Union Intellectual Property Office
Mark type
Figurative mark
1 class
Ownership

Who owns FOCUS-2

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Axsome Therapeutics

AXSM

150 trademarks in the portfolioView company

Representative

Keltie Limited

Keltie Limited

Goods and services

What the mark covers

The products and services FOCUS-2 is filed for, grouped by Nice class.

  • Medicated and pharmaceutical preparations for use in the treatment of ADHD; prescription medicines for the treatment of ADHD

FAQ

About FOCUS-2

Who owns the trademark "FOCUS-2"?

The EUIPO trademark "FOCUS-2" (application 019416545) is owned by Axsome Therapeutics.

What is the status of "FOCUS-2"?

Its status at the EUIPO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull FOCUS-2 and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a060ee-d6fa-719c-93cb-474d10034e3a
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a060ee-d6fa-719c-93cb-474d10034e3a",
  "object": "trademark",
  "mark_text": "FOCUS-2",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "EM",
  "application_number": "019416545",
  "filing_date": "2026-09-01",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Axsome Therapeutics",
      "entity_id": "ent_019ebba6-3220-71b6-8fee-f721d26ca090"
    }
  ]
}